Study shows that when diagnosing knee cartilage defects, 3D and 2D MRIs performed about the same.
Three-dimensional MRI is comparable to two-dimensional MRI in the depiction and characterization of cartilage defects within the knee joint, according to a study published in the journal Radiology.
Researchers from the United States and Iran sought to determine the diagnostic performance of 3D MRI for the depiction and characterization of cartilage defects within the knee joint. This was compared to arthroscopy and/or open surgery as the standard of reference.
The researchers performed a systematic literature search for diagnostic studies published between January 1985 and October 2017. Two independent investigators assessed the methodologic quality of each study by using Quality Assessment of Diagnostic Accuracy Studies 2. The researchers compared the diagnostic odds ratio (DOR) of 3D and two-dimensional (2D) MRI for helping to detect knee cartilage defects and to assess the effect of relevant covariates on diagnostic performance of 3D MRI.
Related article: Study: In-Hospital MRIs Could Be Wasteful
Thirty-seven studies comprising 1,710 MRI examinations were included. Of those, 16 (59%) studies compared the diagnostic performance of 3D and 2D MRI. The diagnostic performance of 3D MRI statistically significantly improved over the last 3 decades. Three-dimensional MRI obtained by using 3.0-T field strength had higher DOR relative to 1.5-T or lower field strength (relative DOR, 4.05). Three-dimensional multiplanar reformation was associated with higher specificity compared with conventional axial, sagittal, and coronal 2D MRI planes. Three-dimensional fast-spin-echo sequences provided higher sensitivity and specificity than did 2D MRI.
The researchers concluded that 3D MRI provided comparable diagnostic performance to two-dimensional MRI, with improvement in diagnostic performance achieved by using 3.0-T field strength, three-dimensional fast-spin-echo sequences, and multiplanar reformation.
MRI Study at ARRS Raises Questions About Disparities in Detection of MASLD
May 3rd 2025New research revealed that Hispanic Americans with evidence of hepatic steatosis on MRI but no formal diagnosis of MASLD had over a fourfold higher risk of developing hepatocellular carcinoma in comparison to those who had a formal diagnosis of MASLD.
FDA Clears MRI-Based AI Segmentation of Organs at Risk During Radiation Therapy
May 2nd 2025Capable of segmenting over 37 organs and structures in the head, neck and pelvis, the MR Contour DL software is currently being showcased at the European Society for Radiotherapy and Oncology (ESTRO) conference.